Home > Insider Trading > Filing (0001209191-21-036104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1770787	10X Genomics Inc.	TXG	Laboratory Analytical Instruments (3826)	455614458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1786720	Serge Saxonov	C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-03-19	24,571	$0.00	905,039	No	4	A	Direct
Class A Common Stock	Disposition	2021-05-24	771	$162.66	904,268	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (right to buy)	Acquisiton	2021-03-19	61,428	$0.00	61,428	$177.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
61,428		2031-03-19	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	89,960	Indirect	See Footnote

Footnotes

These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
The number of shares beneficially owned following the reported transaction is as of March 19, 2021.
These shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.
The number of shares beneficially owned following the reported transaction is as of May 24, 2021.
The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.